December 2014—Thermo Fisher Scientific announced the successful CE-IVD registration of its Ion PGM Dx System for sale in European countries. The system was developed using the Ion Torrent next-generation sequencing technology, currently used in clinical research laboratories to produce tests to uncover meaningful genetic information for a range of human conditions.
The Ion PGM Dx System was validated using a number of challenging germline variants with library kits based on the Ion AmpliSeq technology. To support the accuracy and reproducibility performance requirements of clinical laboratories, the Ion PGM Dx System includes the instruments, GMP reagents, and software controls necessary to establish high-performing next-generation clinical sequencing workflows.
Thermo Fisher Scientific, 760-603-7200